Tirzepatide, an injection medication already approved by the Food and Drug Administration (FDA) to treat Type 2 diabetes, is likely to receive FDA approval for another indication — weight loss — later ...

Post-approval research on existing medicines has improved patient outcomes and addressed unmet medical needs. In oncology, post-approval improvements to drugs reflect indications for additional cancer ...

The Inflation Reduction Act will likely change incentives surrounding single-indication launches and postapproval research for additional indications in small molecule drugs, affecting patient access.

Drug names often draw curiosity and confusion—and they always get a once-over by the FDA. The agency is more than usually interested these days, though. After a round of new guidance issued in ...

Eli Lilly (NYSE: LLY) and Boehringer Ingelheim's supplemental New Drug Application for Jardiance tablets to treat adult patients with chronic kidney disease (CKD) was recently accepted for review by ...

Positron Emission Tomography–Driven Strategy in Advanced Hodgkin Lymphoma: Prolonged Follow-Up of the AHL2011 Phase III Lymphoma Study Association Study Generic competition can be delayed if ...

AUSTIN, Texas, Feb. 19, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Biotechnology mergers and acquisitions (M&As) are increasingly shaped by a clear strategic evolution. Pharmaceutical ...

Jonathan Caplan, Jeffrey Coleman Ph.D. President Biden signed the Inflation Reduction Act (IRA) into law on Aug. 16, 2022, with the goal of reducing health care costs for the government and ...

Please provide your email address to receive an email when new articles are posted on . Pregnant Black patients were significantly more likely to have urine drug screens collected vs. other races and ...

Kao-Ping Chua ([email protected]) is an assistant professor in the Department of Pediatrics and the Susan B. Meister Child Health Evaluation and Research Center at the University of Michigan Medical ...